Anti Tumor Necrosis Factor Alpha (TNFamp;#945;) Therapy in Ankylosing Spondylitis - Asian Perspective

By  

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Knee joint destruction driven by residual local symptoms after anti-tumor necrosis factor therapy in rheumatoid arthritis

By Imagama Takashi  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 823-828

Springer Publishing Company

Access to resources Recommend Favorite

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 446-454

Karger

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

By Kolho Kaija-Leena   Sipponen Taina  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 4, 2014-04 ,pp. : 434-441

Informa Healthcare

Access to resources Recommend Favorite